Table 2.
Disease-related characteristics and mental well-being of participants (N=155) across profiles [data are presented as mean (SD) for continuous variables and numbers (proportions) for frequencies].
| Characteristics | All (N=155) | Profile 1 (n=28, 18.1%) | Profile 2 (n=50, 32.3%) | Profile 3 (n=21, 13.5%) | Profile 4 (n=20, 12.9%) | Profile 5 (n=36, 23.2%) | P value | ||
| Time since diabetes diagnosis, n (%) | .87 | ||||||||
|
|
≤5 years | 124 (80.0) | 22 (78.6) | 42 (82.0) | 16 (76.2) | 15 (75.0) | 29 (80.6) |
|
|
|
|
≥6 years | 31 (20.0) | 6 (21.4) | 8 (16.0) | 5 (23.8) | 5 (25.0) | 7 (19.4) |
|
|
| Type of medication, n (%) | .58 | ||||||||
|
|
None | 19 (12.3) | 4 (14.3) | 8 (16.0) | 3 (14.3) | 1 (5.0) | 3 (8.3) |
|
|
|
|
Peroral | 102 (65.8) | 19 (67.9) | 32 (64.0) | 10 (47.6) | 16 (80.0) | 25 (69.5) |
|
|
|
|
Injection | 34 (21.9) | 5 (17.8) | 10 (20.0) | 8 (38.1) | 3 (15.0) | 8 (22.2) |
|
|
| T2D complications, n (%)a | .37 | ||||||||
|
|
Yes | 90 (73.8) | 5 (22.7) | 7 (18.0) | 6 (35.3) | 7 (41.2) | 7 (25.9) |
|
|
|
|
No | 32 (26.2) | 17 (77.3) | 32 (82.0) | 11 (64.7) | 10 (58.8) | 20 (74.1) |
|
|
| Additional chronic conditions, n (%) | .05 | ||||||||
|
|
No additional conditions | 17 (11.0) | 3 (10.7) | 10 (20.0) | 1 (4.8) | 2 (10.0) | 1 (2.8) |
|
|
|
|
1 additional condition | 60 (38.7) | 13 (46.4) | 23 (46.0) | 5 (23.8) | 7 (35.0) | 12 (33.3) |
|
|
|
|
2+ additional conditions | 78 (50.3) | 12 (42.9) | 17 (34.0) | 15 (71.4) | 11 (55.0) | 23 (63.9) |
|
|
| Mental well-being, mean (SD)b | 59.1 (20.2) | 71.7 (16.3) | 67.3 (14.6) | 42.7 (14.7)c,d | 67.2 (12.7)e | 43.4 (20.1)c,d,f | <.001 | ||
| Risk of depression (score <50), n (%)b | 49 (31.8) | 3 (10.7) | 6 (12.2) | 14 (66.7)c,d | 2 (10.0) e | 24 (66.7)c,d,f | .001 | ||
an=122.
bn=154.
cDifferent from Profile 1, P<.05.
dDifferent from Profile 2, P<.05.
eDifferent from Profile 3, P<.05.
fDifferent from Profile 4, P<.05.